Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

453 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma.
Cloughesy TF, Mochizuki AY, Orpilla JR, Hugo W, Lee AH, Davidson TB, Wang AC, Ellingson BM, Rytlewski JA, Sanders CM, Kawaguchi ES, Du L, Li G, Yong WH, Gaffey SC, Cohen AL, Mellinghoff IK, Lee EQ, Reardon DA, O'Brien BJ, Butowski NA, Nghiemphu PL, Clarke JL, Arrillaga-Romany IC, Colman H, Kaley TJ, de Groot JF, Liau LM, Wen PY, Prins RM. Cloughesy TF, et al. Among authors: cohen al. Nat Med. 2019 Mar;25(3):477-486. doi: 10.1038/s41591-018-0337-7. Epub 2019 Feb 11. Nat Med. 2019. PMID: 30742122 Free PMC article. Clinical Trial.
IDH1 and IDH2 mutations in gliomas.
Cohen AL, Holmen SL, Colman H. Cohen AL, et al. Curr Neurol Neurosci Rep. 2013 May;13(5):345. doi: 10.1007/s11910-013-0345-4. Curr Neurol Neurosci Rep. 2013. PMID: 23532369 Free PMC article. Review.
Glioma biology and molecular markers.
Cohen AL, Colman H. Cohen AL, et al. Cancer Treat Res. 2015;163:15-30. doi: 10.1007/978-3-319-12048-5_2. Cancer Treat Res. 2015. PMID: 25468223 Review.
IGFBP2 expression predicts IDH-mutant glioma patient survival.
Huang LE, Cohen AL, Colman H, Jensen RL, Fults DW, Couldwell WT. Huang LE, et al. Among authors: cohen al. Oncotarget. 2017 Jan 3;8(1):191-202. doi: 10.18632/oncotarget.13329. Oncotarget. 2017. PMID: 27852048 Free PMC article.
Glioma Subclassifications and Their Clinical Significance.
Chen R, Smith-Cohn M, Cohen AL, Colman H. Chen R, et al. Among authors: cohen al. Neurotherapeutics. 2017 Apr;14(2):284-297. doi: 10.1007/s13311-017-0519-x. Neurotherapeutics. 2017. PMID: 28281173 Free PMC article. Review.
453 results